Keybank National Association OH decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 31.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,156 shares of the semiconductor company’s stock after selling 1,468 shares during the quarter. Keybank National Association OH’s holdings in Synopsys were worth $1,373,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. New York Life Investment Management LLC raised its holdings in Synopsys by 3.2% during the 3rd quarter. New York Life Investment Management LLC now owns 32,258 shares of the semiconductor company’s stock worth $14,030,000 after purchasing an additional 986 shares during the last quarter. Kinsale Capital Group Inc. boosted its stake in shares of Synopsys by 26.7% in the 3rd quarter. Kinsale Capital Group Inc. now owns 29,484 shares of the semiconductor company’s stock valued at $12,824,000 after purchasing an additional 6,214 shares during the last quarter. 71 West Capital Partners boosted its stake in shares of Synopsys by 5.5% in the 3rd quarter. 71 West Capital Partners now owns 1,206 shares of the semiconductor company’s stock valued at $525,000 after purchasing an additional 63 shares during the last quarter. Fulcrum Asset Management LLP grew its position in shares of Synopsys by 55.8% during the 3rd quarter. Fulcrum Asset Management LLP now owns 8,705 shares of the semiconductor company’s stock worth $3,613,000 after buying an additional 3,118 shares during the period. Finally, Kornitzer Capital Management Inc. KS grew its position in shares of Synopsys by 96.7% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 3,979 shares of the semiconductor company’s stock worth $1,731,000 after buying an additional 1,956 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Down 1.6%
Shares of SNPS traded down $7.49 during mid-day trading on Friday, hitting $455.20. 2,005,399 shares of the company’s stock were exchanged, compared to its average volume of 1,947,810. The company has a 50-day simple moving average of $445.16 and a 200 day simple moving average of $441.11. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The company has a market cap of $87.23 billion, a PE ratio of 80.42, a P/E/G ratio of 1.47 and a beta of 1.18. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same period in the previous year, the business earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, research analysts forecast that Synopsys, Inc. will post 11.01 earnings per share for the current fiscal year.
Synopsys declared that its board has authorized a stock repurchase program on Monday, October 5th that permits the company to buy back $1 billion in outstanding shares. This buyback authorization permits the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the stock. Roth Capital raised shares of Synopsys to a “buy” rating in a research note on Friday, September 25th. Bank of America raised their price objective on shares of Synopsys from $500.00 to $600.00 in a research note on Thursday, October 1st. Rothschild & Co Redburn lowered their target price on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 23rd. KeyCorp upped their target price on shares of Synopsys from $600.00 to $605.00 and gave the company an “overweight” rating in a research report on Thursday, October 1st. Finally, Mizuho cut their price target on Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a research note on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $575.00.
Check Out Our Latest Stock Analysis on SNPS
Key Stories Impacting Synopsys
Investors following SNPS have been watching these stories:
- Positive Sentiment: Coverage points to AI-powered chip design and verification, expanding EDA capabilities and the Ansys integration as potential growth drivers. A Seeking Alpha article also argues Synopsys could exceed growth estimates. Can AI-Driven EDA Accelerate Synopsys’ Next Growth Phase? Synopsys Looks Poised To Outperform Growth Estimates
- Negative Sentiment: One report says SNPS had fallen nearly 10% over a week and highlights export-control risks, signaling investor caution despite the company’s exposure to AI-chip development. Synopsys Investment Outlook and Risks
- Negative Sentiment: ETFs were reported as net sellers of Synopsys shares, disposing of $10.1 million on Nov. 11—a potential source of near-term selling pressure. ETFs Are Net Sellers of Synopsys
Insider Activity at Synopsys
In other news, CFO Sudhindra Kankanwadi sold 9,170 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the sale, the chief financial officer owned 22,717 shares in the company, valued at $11,358,500. The trade was a 28.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Janet Lee sold 1,144 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total value of $574,882.88. Following the sale, the insider owned 16,534 shares of the company’s stock, valued at approximately $8,308,665.68. This represents a 6.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 117,163 shares of company stock valued at $51,366,457. 0.56% of the stock is currently owned by insiders.
Synopsys Profile
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Read More
- Five stocks we like better than Synopsys
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
